Program: First European Annual Primary Care MASLD/MASH Summit 2025

Thursday, December 4, 2025
6:00 PM - 6:05 PM																Welcome & Opening Remarks Marko Korenjak, ELPA - European Liver Patients Association Mike Betel, Fatty Liver Alliance
6:05 PM - 6:30 PM																Understanding MASLD and MASH and the relationship between Primary Care and the Hepatologist MASLD & MASH simplified: clear, practical definitions Screening criteria and risk factors Brief review of updated guidelines and nomenclature Jörn Schattenberg, University Medical Center Homburg
6:30 PM - 7:00 PM																Primary Care Toolbox: Managing Fatty Liver in Daily Practice People-First Liver Charter What labs to order How to integrate liver health into patients visits Importance of NITs: FIB-4, FibroScan, ultrasound, ELF, and non-invasive scores. When and how to use them Louise Campbell, Tawazun Health Jeffrey Lazarus, CUNY Graduate School of Public Health and Health Policy
7:00 PM - 7:25 PM																The Patient Voice: Obesity and Liver Disease Why the patient’s voice is so important? How patients found out they had MASLD/MASH Barriers to care (stigma, confusion, fear) How Primary Care made (or could have made) a difference José Willemse, Liver Patients International Una Keightley, Dr. Stephen A. Harrison Advocacy Fellow
7:25 PM - 7:55 PM																Lifestyle Rx: Pearls for a busy Primary Care Practice Addressing real world nutritional advice – Practical strategies for Primary Care Addressing patient challenges and stigma Brief and Practical lifestyle intervention strategies for busy clinics Shira Zelber-Sagi Shira, University of Haifa, EASL, researcher at GNC Jonathan Stine, Penn State Health Milton S. Hershey Medical Center
7:55 PM - 8:25 PM																Integrating Available Medications in Primary Care for management of Fatty Liver disease Role of GLP-1s, statins, insulin sensitizers, and upcoming MASH therapies Considerations for T2D, obesity, CKD, and polypharmacy What’s in the pipeline Diabetes Canada Guidelines / CanMASLD Guidelines? Aleksander Krag, Odense University Hospital Vlad Ratziu, Hospital Pitié salpêtrière, ICAN
8:25 PM - 8:55 PM																Case-Based Panel: What Would You Do? Newly diagnosed patient with elevated ALT & diabetes Patient with advanced fibrosis on FibroScan but no symptoms Young patient with obesity and normal liver enzymes Aleksander Krag, Odense University Hospital Vlad Ratziu, Hospital Pitié salpêtrière, ICAN Shira Zelber-Sagi Shira, University of Haifa, EASL, researcher at GNC Una Keightley, Dr. Stephen A. Harrison Advocacy Fellow
8:55 PM - 9:00 PM																Closing Remarks: Primary Care as Liver Health Leaders Mike Betel, Fatty Liver Alliance

Time Zone: (UTC+01:00) Berlin, Bern []

Louise Campbell
Clinical Director
Tawazun Health

James Kim
General Practitioner
University of Calgary

Marko Korenjak
President
ELPA - European Liver Patients Association

Aleksander Krag
Professor
Odense University Hospital

Jeffrey Lazarus
Professor
CUNY Graduate School of Public Health and Health Policy

Vlad Ratziu
Professor
Hospital Pitié salpêtrière, ICAN

Jörn Schattenberg
Professor of Medicine and Director of the Department of Medicine II
University Medical Center Homburg

Shira Zelber-Sagi Shira
Prof at the University of Haifa, Cahir of public health at EASL
University of Haifa, EASL, researcher at GNC

Jonathan Stine
Clinical Professor of Medicine
Penn State Health Milton S. Hershey Medical Center

José Willemse
patient advocate / board member Liver Patients International
Liver Patients International

Mike Betel
President and Founder
Fatty Liver Alliance

Una Keightley
Patient advocate
Dr. Stephen A. Harrison Advocacy Fellow

PRELIMINARY AGENDA